KLOW ProtocolHealing / aesthetic research blendBlendSafety Rating 7/10
Price Comparison
Compare vendors
Research details
KLOW Protocol — research data
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Overview
About KLOW Protocol
Mechanism of action
Four-peptide combination building on GLOW by adding KPV. A typical 80 mg blend is ~50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157, 10 mg KPV (5:1:1:1). Each contributes a separate mechanism: GHK-Cu gene/collagen modulation, TB-500 cell migration and angiogenesis, BPC-157 growth-factor signaling, and KPV NF-kB inhibition (anti-inflammatory). There are no clinical trials on the four-peptide combination.
Safety profile
Injection-site reactions (KPV may reduce these versus GLOW); temporary blue-green skin discoloration (copper); water retention; the main risk is overdosing an individual component. No safety studies exist on the four-peptide combination. Research-use only; not for human consumption. · Marketed four-peptide blend (GHK-Cu + TB-500 + BPC-157 + KPV); generally well-tolerated components, but NO combination-specific safety/clinical studies. Fixed-ratio dosing caveat applies; pro-angiogenic components carry a cancer contraindication.
Storage
Stability & handling
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops KLOW Protocol below your target.
Blend
Component Compounds
BPC-157
VEGFR2/angiogenesis, GI protection
TB-500
Actin binding, cell migration, anti-inflammatory
GHK-Cu
Collagen synthesis, antioxidant, wound healing
KPV
MCR-independent anti-inflammatory, gut protection
Related pages
More on KLOW Protocol
Stack & Compare
Frequently Researched Together
Research
Studies & key findings
- KLOW is a four-peptide COMBINATION (GHK-Cu + TB-500 + BPC-157 + KPV) — it builds on the GLOW blend by adding KPV for anti-inflammatory (NF-κB-inhibiting) action.
- There are NO clinical trials, safety studies, or peer-reviewed research on this specific four-peptide combination — it is investigational, with only theoretical synergy from the individual components.